References
- PincusTO’DellJRKremerJMCombination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategyAnn Intern Med19991311076877410577301
- SvartzNThe treatment of rheumatic polyarthritis with acid azo compoundsRheumatism19484118018518915673
- BrownTMClarkHWBaileyJSGrayCWA mechanistic approach to treatment of rheumatoid type arthritis naturally occurring in a gorillaTrans Am Clin Climatol Assoc1971822272474104221
- KloppenburgMBreedveldFCTerwielJPMalleeCDijkmansBAMinocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trialArthritis Rheum19943756296368185689
- TilleyBCAlarcónGSHeyseSPMinocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial GroupAnn Intern Med1995122281897993000
- O’DellJRHaireCEPalmerWTreatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trialArthritis Rheum19974058428489153544
- O’DellJRBlakelyKWMallekJATreatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquineArthritis Rheum200144102235224111665963
- OgrendikMKokinoSOzdemirFBirdPSHamletSSerum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritisMed Gen Med2005722
- MoenKBrunJGValenMSynovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAsClin Exp Rheumatol200624665666317207381
- LundbergKKinlochAFisherBAAntibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolaseArthritis Rheum200858103009301918821669
- MikulsTRPayneJBReinhardtRAAntibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitisInt Immunopharmacol200991384218848647
- Martinez-MartinezREAbud-MendozaCPatiño-MarinNRizo-RodríguezJCLittleJWLoyola-RodríguezJPDetection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patientsJ Clin Periodontol200936121004101019929953
- BartoldPMMarinoVCantleyMHaynesDREffect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritisJ Clin Periodontol201037540541120507365
- CantleyMDHaynesDRMarinoVBartoldPMPre-existing periodontitis exacerbates experimental arthritis in a mouse modelJ Clin Periodontol201138653254121434962
- KinlochAJAlzabinSBrintnellWImmunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic miceArthritis Rheum201163123818382321953289
- ReichertSHaffnerMKeyßerGDetection of oral bacterial DNA in synovial fluidJ Clin Periodontol201340659159823534379
- McConkeyBAmosRSDurhamSForsterPJHubballSWalshLSulphasalazine in rheumatoid arthritisBr Med J198028062124424446102877
- HoultJRPharmacological and biochemical actions of sulphasalazineDrugs198632Suppl 118262877850
- PullarTHunterJACapellHAWhich component of sulphasalazine is active in rheumatoid arthritis?Br Med J (Clin Res Ed)1985290648115351538
- AshGBakerRRajapakseCSwinsonDRStudy of sulphamethoxazole in rheumatoid arthritisBr J Rheumatol19862532852873524728
- OstranderFDVitamins, sulfonamides and antibiotics in periodontal therapyJ Am Dent Assoc194837327928818884488
- FelsonDTAndersonJJMeenanRFUse of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trialsArthritis Rheum19923510111711251358078
- WeinblattMERedaDHendersonWSulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trialsJ Rheumatol199926102123213010529127
- ScottDLDacreJEAdverse reactions to sulfasalazine: the British experienceJ Rheumatol Suppl19881617212903924
- AlarcónGSTetracyclines for the treatment of rheumatoid arthritisExpert Opin Investig Drugs20009714918
- NakaoRTakigawaSSuganoNImpact of minocycline ointment for periodontal treatment of oral bacteriaJpn J Infect Dis201164215616021519133
- KwiatkowskaBMaślińskaMMacrolide therapy in chronic inflammatory diseasesMediators Inflamm2012201263615722969171
- OgrendikMEffects of clarithromycin in patients with active rheumatoid arthritisCurr Med Res Opin200723351552217355733
- SaviolaGAbdi AliLRossiniPClarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot studyClin Exp Rheumatol200220337337812102474
- SaviolaGAbdi-AliLCampostriniLClarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value-a 24-month single-blind pilot studyRheumatol Int201333112833283823864141
- OgrendikMEfficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trialClin Ther20093181754176419808134
- OgrendikMKaragozNTreatment of rheumatoid arthritis with roxithromycin: a randomized trialPostgrad Med2011123522022721904105
- ZuckermanJMQamarFBonoBRMacrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecyclineInfect Dis Clin North Am20092349971026 ix19909895
- DrlicaKZhaoXDNA gyrase, topoisomerase IV, and the 4-quinolonesMicrobiol Mol Biol Rev19976133773929293187
- MartinSJMeyerJMChuckSKJungRMessickCRPendlandSLLevofloxacin and sparfloxacin: new quinolone antibioticsAnn Pharmacother19983233203369533064
- OgrendikMLevofloxacin treatment in patients with rheumatoid arthritis receiving methotrexateSouth Med J2007100213513917330681
- LiuHHSafety profile of the fluoroquinolones: focus on levofloxacinDrug Saf201033535336920397737
- OgrendikMRheumatoid arthritis is an autoimmune disease caused by periodontal pathogensInt J Gen Med2013638338623737674